The Food and Drug Administration approved the first copycat version of a biologic drug in the United States, allowing a Swiss company to sell a knockoff of Amgen Inc.’s chemotherapy recovery drug Neupogen.

Topics:  food   drug administration   united states   swiss   amgen   neupogen   chemotherapy   
BING NEWS:
  • FDA Approves Amgen's Blincyto as Consolidation Treatment in Certain Pediatric, Adult ALL Patients
    Adult and pediatric patients with CD19-positive, Philadelphia chromosome-negative B-cell precursor ALL will be eligible for the treatment.
    06/17/2024 - 5:27 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News